Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 2/2016

01-04-2016 | Commentary

Medical care and drug-related problems: Do doctors and pharmacists speak the same language?

Authors: J. W. Foppe van Mil, Tommy Westerlund, Lawrence Brown, Timothy F. Chen, Martin Henman, Kurt Hersberger, James McElnay, Martin Schulz

Published in: International Journal of Clinical Pharmacy | Issue 2/2016

Login to get access

Abstract

Optimal communication between physicians and pharmacists is important for patient care. However, pharmacists and doctors do not always seem to understand each other. They have been professionalized differently, and do not always speak the same language. Especially in the areas of prescribing, medication review, and medicine use, there can be differences in views. This contribution clarifies some essential concepts that doctors and pharmacists use. Thus we hope that our commentary contributes to a better understanding of each other's role and the importance of interprofessional cooperation for the benefit of the patient.
Literature
1.
Institute of Medicines. To err is human: building a safer health system. In: Kohn LT, Corrigan JM, Donaldson MS, editors. Washington; 1999. ISBN: 0-309-06837-1.
2.
Phillips DP, Christenfeld N, Glynn LM. Increase in US medication-error deaths between 1983 and 1993. Lancet. 1998;351(9103):643–4.CrossRefPubMed
3.
Stelfox HT, Palmisani S, Scurlock C, Orav EJ, Bates DW. The “To err is human” report and the patient safety literature. Qual Saf Health Care. 2006;15:174–8.CrossRefPubMedPubMedCentral
4.
5.
6.
Benjamin J, Basger BJ, Moles RJ, Chen TF. Development of an aggregated system for classifying causes of drug-related problems. Ann Pharmacother. 2015;49:405–18.CrossRef
7.
8.
van Mil JWF, Westerlund LOT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859–67.CrossRefPubMed
9.
10.
Rupp MT, DeYoung M, Schondelmeyer SW. Prescribing problems and pharmacist interventions in community practice. Med Care. 1992;30(10):926–40.CrossRefPubMed
11.
Dean B, Schachter M, Vincent C, Barber N. Prescribing errors in hospital inpatients: their incidence and clinical significance. Qual Saf Health Care. 2002;11(4):340–4.CrossRefPubMedPubMedCentral
12.
13.
Institute of Medicine. Preventing medication errors: quality chasm series. Washington, DC: National Academy Press; 2006.
14.
15.
Hanlon JT, Schmader KE, Semla TP. Update of studies on drug-related problems in older adults. J Am Geriatr Soc. 2013;61(8):1365–8.CrossRefPubMed
16.
van Doormaal JE, van den Bemt PM, Mol PG, Zaal RJ, Egberts AC, Kosterink JG, et al. Medication errors: the impact of prescribing and transcribing errors on preventable harm in hospitalised patients. Qual Saf Health Care. 2009;18(1):22–7.CrossRefPubMed
17.
Basger BJ, Moles RJ, Chen TF. Application of drug-related problem (DRP) classification systems: a review of the literature. Eur J Clin Pharmacol. 2014;70:799–815.CrossRefPubMed
18.
Kaufmann CP, Stämpfli D, Hersberger KE, et al. Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ Open. 2015;5(3):e006376.CrossRefPubMedPubMedCentral
19.
Allemann SS, van Mil JW, Botermann L, Berger K, Griese N, Hersberger KE. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544–55.CrossRefPubMed
20.
Burke JM, Miller WA, Spencer AP, et al. Clinical pharmacist competencies. Pharmacotherapy. 2008;28:806–15.CrossRefPubMed
21.
Metadata
Title
Medical care and drug-related problems: Do doctors and pharmacists speak the same language?
Authors
J. W. Foppe van Mil
Tommy Westerlund
Lawrence Brown
Timothy F. Chen
Martin Henman
Kurt Hersberger
James McElnay
Martin Schulz
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 2/2016
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-016-0249-x

Other articles of this Issue 2/2016

International Journal of Clinical Pharmacy 2/2016 Go to the issue

Short Research Report

Consumption of medicinal plants by patients with heart diseases at a pharmacist-managed anticoagulation clinic in Brazil

Research Article

Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium

Research Article

Exploring the relationship between fall risk-increasing drugs and fall-related fractures

Research Article

Clinical and conventional pharmacy services in Polish hospitals: a national survey

Research Article

The influence of organisational climate on care of patients with schizophrenia: a qualitative analysis of health care professionals’ views

Research Article

Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depression
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits